Preoperative evaluation of renal cell carcinoma patients with bone metastases on risks for blood loss, performance status and lethal event
Authors:
- 1 September 2017
- journal article
- Published by Elsevier in Journal of Orthopaedic Science
- Vol. 22 (5) , 924-930
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development (16ck0106087h0003)
This publication has 26 references indexed in Scilit:
- Deep infection in tumor endoprosthesis around the knee: a multi-institutional study by the Japanese musculoskeletal oncology groupBMC Musculoskeletal Disorders, 2013
- Clinical efficacy and prognostic factors for overall survival in Japanese patients with metastatic renal cell cancer treated with sunitinibBJU International, 2011
- Estimating Survival in Patients with Operable Skeletal Metastases: An Application of a Bayesian Belief NetworkPLOS ONE, 2011
- Survival after complete surgical resection of multiple metastases from renal cell carcinomaCancer, 2011
- Venous thromboembolism in the management of patients with musculoskeletal tumorJournal of Orthopaedic Science, 2010
- Bone metastases from renal cell carcinoma: patient survival after surgical treatmentBMC Musculoskeletal Disorders, 2010
- Performance status and cytoreductive nephrectomyCancer, 2008
- Blood loss and transfusion associated with musculoskeletal tumor surgeryJournal of Surgical Oncology, 2005
- Survival in Patients Operated on for Pathologic Fracture: Implications for End-of-Life Orthopedic CareJournal of Clinical Oncology, 2005
- Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinomaCancer, 2003